Avasopasem
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Avasopasem, covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy [Phase 1]